Nexalin Technology, Inc. announced on August 1, 2025, the appointment of Justin Van Fleet, CPA, as Chief Financial Officer, effective the same day. Mr. Van Fleet brings over 20 years of experience in public accounting and assurance services, having most recently served as Partner at Marcum LLP.
In his previous role, Mr. Van Fleet led the firm’s assurance practice and advised publicly traded and privately held clients across various sectors, including technology and life sciences. He is recognized for his expertise in guiding companies through complex financial transactions such as IPOs and mergers.
As CFO, Mr. Van Fleet will oversee Nexalin’s financial strategy, planning, and reporting functions. This appointment is crucial as the company advances its innovative, non-invasive neurostimulation systems through regulatory review and into commercial readiness, supporting its next phase of growth and strategic initiatives.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.